Research & Analysis [1]
Featured

Member Survey 2025

Member Survey 2025

USTR Opens Comments on China Tariff Reductions, Proposes New 12.5% Tariff

USTR Opens Comments on China Tariff Reductions, Proposes New 12.5% Tariff

US, China Embrace Strategic Stability, But Implementation Questions Remain

US, China Embrace Strategic Stability, But Implementation Questions Remain

Trump-Xi Summit Nears, Congressional Delegation Visits China

Trump-Xi Summit Nears, Congressional Delegation Visits China
Advocacy [2]
Events [3]
About [4]
Join USCBC [5]

USCBC Fujian Drug Advocacy Letter

June 23, 2017

Fujian Drug Price Reform Letter: Letter seeking delayed implementation of drug price reform pilot

Read the full comment letter here.

USCBC Fujian Drug Advocacy Letter

Related Posts

USTR Opens Comments on China Tariff Reductions, Proposes New 12.5% Tariff

Member Exclusive

USTR Opens Comments on China Tariff Reductions, Proposes New 12.5% Tariff

Washington Update USCBC Government Affairs

June 4, 2026

US-China Trade War Tracker

Member Exclusive

US-China Trade War Tracker

Tracker

June 2, 2026

Assessing the US-China Tech Competition — And What’s At Stake

Assessing the US-China Tech Competition — And What’s At Stake

Interview Mira Anderson

June 1, 2026

Primer: China’s Retaliatory Tools

Member Exclusive

Primer: China’s Retaliatory Tools

China Market Intelligence Wenqing Ge, Claire Zhao

May 27, 2026

Register now!

53rd Annual Membership Meeting

53rd Annual Membership Meeting

June 16